TickerFacts.

Company research / CLGN

CollPlant Biotechnologies Ltd (CLGN)

Build a valuation ↗↓ Download CSV

CIK 0001631487 · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, CollPlant Biotechnologies Ltd reported revenue of $2.37M. Revenue grew 360.4% from the prior annual period.

Key ratios (year ended 2025-12-31)

64.8%
Gross margin
-484.3%
Operating margin
-484.6%
Net margin
-188.9%
Return on year-end equity
360.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-10-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue$2.37M$515.0K$10.96M$299.0K$15.64M$6.14M$2.32M$5.01Mn/a
Cost of Revenue$835.0K$1.62M$1.99M$400.0K$2.00M$3.00M$1.88M$1.66Mn/a
Gross Profit$1.54M-$1.11M$8.97M-$101.0K$13.64M$3.13M$439.0K$3.35Mn/a
R&D Expense$8.19M$10.52M$10.48M$10.26M$7.63M$4.07M$4.41M$3.88M$584.0K
Operating Income-$11.48M-$17.25M-$7.51M-$17.10M$65.0K-$5.60M-$7.63M-$4.25Mn/a
Depreciation & Amortization$912.0K$1.04M$1.10M$1.08M$773.0Kn/an/an/an/a
EBITDA-$10.57M-$16.21M-$6.41M-$16.02M$838.0Kn/an/an/an/a
Net Income-$11.49M-$16.61M-$7.02M-$16.93M$237.0K-$5.77M-$11.16M-$6.25Mn/a
EPS (Diluted)-$0.94-$1.45-$0.62-$1.53$0.02-$0.84-$2.23n/an/a
Total Assets$10.79M$18.71M$34.13M$37.77M$51.22M$10.84M$10.75Mn/an/a
Total Liabilities$4.70M$5.25M$5.79M$5.49M$6.10M$6.36M$6.66Mn/an/a
Long-Term Debtn/an/an/an/a$30.0K$11.0K$63.0Kn/an/a
Shareholders' Equity$6.08M$13.46M$28.34M$32.28M$45.12M$4.48M$4.09M$5.42Mn/a
Cash & Equivalents$5.59M$11.91M$26.67M$29.65M$13.15M$3.33M$3.79M$5.35Mn/a
Operating Cash Flow-$9.42M-$14.09M-$2.76M-$13.70M$2.50M-$4.45M-$5.70M-$1.22Mn/a
Capital Expenditures$28.0K$483.0K$954.0K$1.27M$1.43M$437.0K$1.49M$832.0Kn/a
Free Cash Flow-$9.45M-$14.58M-$3.72M-$14.97M$1.07M-$4.89M-$7.19M-$2.05Mn/a
Shares Outstanding12.80M11.45M11.45M11.19M10.77M6.96M5.67Mn/an/a
Weighted Average Diluted Shares12.20M11.45M11.39M11.03M11.97M6.89M4.99Mn/an/a
EPS (Basic)-$0.94-$1.45-$0.62-$1.53$0.02-$0.84-$2.23n/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView